Antibody Engineering Screening
Antibody Engineering Screening is a methodological framework within antibody screening that systematically evaluates engineered antibodies for desired functional and structural properties through iterative design and selection processes.
23
Publications
524
Citations
200
Authors
67
Institutions
Publications per year
2017–2026
15
Parents
23
Mathias Schmidt, Evangelia Vakalopoulou, DW Schneider et al. · British Journal of Cancer · 1997 · 43 citations · Full text
1–5 of 23
200
2
h-index
2
h-index
2
h-index
1
h-index
1
h-index
1–5 of 200
67
National Institutes of Health
Bethesda, United States
2 h-index
4 publications
63 citations
ETH Zurich
Zurich, Switzerland
2 h-index
9 publications
277 citations
National Cancer Institute
Bethesda, United States
2 h-index
4 publications
63 citations
Sanofi (United States)
Bridgewater, United States
1 h-index
1 publications
17 citations
Ithaca College
Ithaca, United States
1 h-index
1 publications
25 citations
Nebraska Medical Center
Omaha, United States
1 h-index
2 publications
26 citations
Huadong Hospital
Shanghai, China
1 h-index
6 publications
72 citations
Institute of Systems, Information Technologies and Nanotechnologies
Fukuoka, Japan
1 h-index
1 publications
11 citations
1–8 of 67
JMB · 3 publications · 94 citations
3
h-index
2 publications · 37 citations
2
h-index
2 publications · 50 citations
2
h-index
Book series · 2 publications · 27 citations
2
h-index
2 publications · 36 citations
2
h-index
1–5